The First Direct Measurement of Chronic Fatigue Syndrome and Related Illness in Patients with Type 2 Diabetes

The first direct measurement of chronic fatigue syndrome and related illness has been achieved in a group of people with Type II diabetes, the researchers reported.

The study was led by researchers at the University of Wisconsin-Madison and the National Institute on Aging (NIA), both of which have significant expertise in this area.

In the new study, the team used an instrument called a continuous glucose meter (CGM) to measure blood sugar levels over a period of five days.

The CGM measures blood sugar and glucose levels directly, and it can be used to monitor the blood sugar level in diabetic patients.

Previous research has used the CGM to measure the severity of symptoms and to assess how quickly and accurately the person is able to control their symptoms.

The study found that, compared with those with Type 1 diabetes, people with type 2 diabetes had better glucose tolerance, less fatigue and less sleep disruption.

The researchers noted that there was no difference in the amount of glucose the patients had in their blood as measured by the Cgm.

However, the Cmg was used in patients who had a higher prevalence of type 2 and Type 1 conditions.

“We did not see any difference in glucose tolerance between those with type 1 and type 2 disease, or between those on the high and low glucose tolerance diets,” said study senior author Ramiro F. Vidal, PhD, a postdoctoral researcher in UW-Madison’s Department of Neurology and Department of Biomedical Engineering.

“But, the fact that there is no difference is significant.”

The Cgm also provides a tool for measuring other chronic health conditions, including sleep disturbance, cardiovascular disease, diabetes, and obesity.

In addition, the study found, people who have chronic fatigue symptoms are more likely to have heart disease and diabetes, as well as other chronic conditions, such as high blood pressure and asthma.

The CGM has become increasingly popular as a method for monitoring the health status of people, including people with diabetes, for a variety of reasons, such for screening for heart disease or diabetes, to help people manage their symptoms, and to help patients who are unable to take care of themselves because of the condition.

The researchers found that people with chronic fatigue were more likely than others to have sleep disturbance and fatigue, which is associated with chronic illness.

“Our findings support the use of CGM for the detection and management of chronic health disorders,” Vidal said.

“The Cmg provides a way to measure and track a wide range of chronic conditions and provides patients with a clear measure of their health status.”

The researchers are currently developing a device to measure sleep disturbances and the use it might have in diagnosing and treating the condition, and will report their findings to the National Institutes of Health in the coming months.

“This is an important step in the development of a more accurate, cost-effective, and reliable method for assessing the severity and severity of fatigue,” said Vidal.

“The next step is to explore ways to incorporate this information in other ways to improve patient care.”

About the University at UW-MilwaukeeFounded in 1879, the University-Milwaukehive School of Medicine is a leader in research in the area of chronic disease management, rehabilitation, and research in clinical and translational science.

For more information, please visit www.milwau.edu.